6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 28-30 | Hybrid Event
CRISPR & Genome Editing Technologies
The advent of CRISPR & genome editing technologies has ushered in a new era of genetic precision, enabling targeted modifications with unprecedented accuracy. CRISPR-Cas systems allow scientists to cut, delete, or replace DNA sequences in a wide range of organisms, offering therapeutic possibilities for genetic diseases, cancer, and infectious conditions. Beyond CRISPR, novel editing tools like base editors and prime editors are expanding the genome editing toolkit. Researchers are now combining CRISPR & Genome Editing Technologies with delivery platforms such as viral vectors and nanoparticles to improve efficiency and specificity. These tools are also critical for functional genomics, crop enhancement, and synthetic biology. As ethical and regulatory frameworks evolve, genome editing remains one of the most transformative technologies in modern biotechnology.
Thomas J Webster
Brown University, United States
Murray Moo Young
University of Waterloo, Canada
Limongi Tania
University of Turin, Italy
K R Aneja
Kurukshetra University, India
Gunjan Mukherjee
Chandigarh University, India
Md Monir Hossain
RMIT University, Australia
Tamer Z Salem
Zewail City of Science and Technology, EgyptSubmit your abstract Today
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Phage Display-Based Biosensing for Rapid Detection of Neonatal Group B Streptococcal (GBS) Infection
Md Monir Hossain, RMIT University, Australia
Title : Contribution of bioengineered food in addressing hunger and food and nutrition security (FNS)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States